SHEEREYES PN

SHEEREYES – Polynucleotide Treatment for Eye Rejuvenation

Composition: Sodium polynucleotide – 2 mg/mL
Syringe Volume: 1.1mL (1 syringe/box)
Recommended Needle Size: 32g
Storage: 1-30°C
Injection Interval: Every 3-4 weeks

(1 MESO-NEEDLE FREE, 32G 4mm)

SHEEREYES is a high-quality tissue simulator with PN(polynucleotide: PDRN) as it’s main ingredient.

PN is extracted and purified from salmon, which has the most similar to human DNA sequence, and is safe to use on sensitive skin with no side effects.

This advanced polynucleotide treatment is particularly effective for:

• Reducing wrinkles around the eyes
• Removing eye bags
• Improving elasticity and skin texture

The treatment also enhances skin regeneration and helps improve dark circles.

How to inject:

• Prior to injection, make ensure the disinfection of the application area.
• Inject slowly the injectable solution into the dermis, the injection volume can be varied depending on the application area.
• Inject the same amount (1.1cc for eye area)
• 3~4 weeks interval between treatments
• After treatment, massage skin for spreading evenly.

Treatment process:

The full effect of SHEEREYES is achieved in 3-4 sessions, with 3-4 weeks between sessions.

• After 3-5 days skin will be revitalized and feel softer.
• After 2-4 weeks Enhanced skin elasticity and disappearance of small wrinkles.
• After 4-6 weeks Skin firmness will improve alone with lifting effects.

Effects:

• Reduce dark circles
• Anti-aging
• Facial wrinkle
• Eye bag removal
• Skin whitening & Elasticity
• Rejuvenate

Suggested Areas for Application

• Under eye area
• Wrinkles around eyes
• Dark circles area

Why Choose SHEEREYES Polynucleotide Treatment?

• Non-Surgical: SHEEREYES is a non-invasive skin booster that offers a non-surgical solution, eliminating the need for painful, costly surgeries.

• Effective Results: Noticeable improvements in skin texture, elasticity, and overall appearance.

• Minimal Downtime: Fast recovery with no significant side effects or recovery time.